OLD and 6 drugs downregulated GLS1 and HK2, two targets of the drugs schemes, as well as CPT1C, a regulator of fatty acids transport into mitochondria for β-oxidation and of cancer cell senescence through metabolic reprogramming17. Here, HK2 is linked to cancer.